Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 14, 2009


Frank Witney, executive vice president and chief commercial officer of Affymetrix, resigned from the company on April 10, according to a filing with the US Securities and Exchange Commission.

Witney joined Affy through its acquisition of Panomics last December, and had been overseeing the integration of Affy’s recently acquired companies — Panomics, True Materials, and USB.

Paul Keim has been named to Febit’s scientific advisory board. Keim is senior investigator and director of the pathogen genomics division at the Translational Genomics Research Institute in Phoenix, Ariz., and regents professor of biology at the Northern Arizona University.

Signature Genomic Laboratories has appointed Trilochan Sahoo as a laboratory director.

Prior to joining Signature, Sahoo spent six years as an assistant professor in the department of molecular and human genetics at Baylor College of Medicine in Houston.

He received his MD in clinical microbiology from Christian Medical College and Hospital in Vellore, India, and completed his postdoc work at the Government of India department of biotechnology and the Duke University Medical Center departments of microbiology and genetics.

Navigenics has appointed Jack Lord to take over the office of president and CEO, which was vacated by Mari Baker, who has taken over as CEO at PlayFirst. Lord was chief innovation officer at Humana, and before that he was president of Health Dialog. He also has been COO of the American Hospital Association, executive VP of Anne Arundel Medical Center, and executive VP of Sun Health.

Patrick Terry will join the board of directors at TcLand Expression, a company focused on gene-expression biomarkers in immunology. Terry is a co-founder and former director of Genomic Health, and he is a founder of the Personalized Medicine Coalition and the Coalition for 21st Century Medicine. He also is a co-founder and former president of the International Genetic Alliance.

Lutz Kirchrath has become managing director of European field operations at NuGen Technologies, where he will lead both sales and technical support functions. Most recently, Kirchrath was European pharmaceutical district manager for Affymetrix. Prior to that, he spent nearly five years in sales development and applications support with Amersham Pharmacia Biotech in Freiburg, Germany. Kirchrath holds a doctorate in microbiology and molecular genetics, and a diploma in biology, from the Heinrich-Heine Universität in Düsseldorf, Germany.